Fact CheckerSign in

NCT07642375Recruiting

Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients

Observational, Randomized, Prospective Study of the Impact of Digital Health Interventions on Symptom and Side-Effect Management in Patients With Metastatic Sarcoma

Source: ClinicalTrials.gov · Last updated 11 Jun 2026

Brief summary (registry, in English)

The objective of this prospective study is to capture the quality of life of patients with locally advanced or metastatic sarcoma, and investigate the effectiveness of support provided through a personalized web-based platform.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
108 (estimated)
First submitted
21 Apr 2026
Start date
22 Aug 2023
Primary completion date
Aug 2026
Lead sponsor
CareAcross
Diseases
Sarcoma
NCT number
NCT07642375

What you commit to

  • Study type: Interventional
  • Planned participants: 108
  • From 22 Aug 2023 to the primary completion date, Aug 2026
  • 11 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation in an interventional clinical trial with investigational drugs or devices.

Other

  • Limited ability or willingness to report side-effects on an online platform.
  • Performance status \>3.
  • Life expectancy of \<6 months.

Who the study is looking for

  • Age of ≥ 18 years.
  • Diagnosis of locally advanced or metastatic sarcoma of any location and origin.
  • Ability to understand and operate in a digital environment.
  • Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line.
  • Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (11)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Metropolitan General Hospital
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Mitera Hospital
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Attikon Hospital, 2nd clinic
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
401 General Military Hospital
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
HYGEIA Hospital
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
251 Air Force General Hospital
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Attikon Hospital, 4th clinic
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Ippokrateio General Hospital
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Ippokratio General Hospital of Thessaloniki
Coordinator of this site? Confirm its status
ThessalonikiGreeceRecruiting
Papageorgiou General Hospital
Coordinator of this site? Confirm its status
ThessalonikiGreeceRecruiting
Bioclinic
Coordinator of this site? Confirm its status
ThessalonikiGreeceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.